Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remazolam with low-dose remifentanil for bronchoscopy
ChiCTR2100047138Phase 4Recruiting
- Sponsor
- Shaoxing Central Hospital
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam mesylate in bronchopulmonary diseases (3 arms), sponsored by Shaoxing Central Hospital. Primary endpoints: Evaluation of anesthetic effect, Improved vigilance/sedation score and 3 more. Started Aug 2020; status: recruiting.
02
Drugs
remimazolam mesylate
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2100047138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047138.